{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:39:28Z","timestamp":1792525168862,"version":"4.5.0"},"reference-count":20,"publisher":"American Diabetes Association","issue":"11","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/100013528","name":"Diabetes Canada","doi-asserted-by":"publisher","award":["OG-3-21-5572-BP"],"award-info":[{"award-number":["OG-3-21-5572-BP"]}],"id":[{"id":"10.13039\/100013528","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Independent of clinical risk factors, performing well-day capillary ketone monitoring over a month predicts near-term diabetic ketoacidosis (DKA) risk. We aimed to determine the minimum frequency of tests needed to maintain similar accuracy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>Using regression and machine-learning gradient-boosted tree (GBT) models on the Empagliflozin as Adjunctive to Insulin Therapy 2 (EASE-2) and EASE-3 trial repository (n = 1,410), we simulated the testing frequencies of capillary ketones over a 1-month interval for predicting DKA or severe ketosis in the next month.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Compared with the baseline twice-weekly ketone testing frequency, once-weekly well-day ketone testing was the lowest frequency that maintained prediction accuracy in maximum ketone models (area under the receiver operating characteristic curve 0.692 vs. 0.678; P = 0.19) and GBT models (0.719 vs. 0.711; P = 0.38).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Weekly well-day capillary ketone testing, using existing strips before they expire, may provide a practical approach to stratify baseline DKA risk while reducing testing burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc26-1110","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:45:10Z","timestamp":1787924710000},"page":"2008-2012","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":0,"title":["The Minimum Frequency of Well-Day Capillary Blood Ketone Testing Needed to Predict 1-Month Diabetic Ketoacidosis Risk in Type 1 Diabetes"],"prefix":"10.2337","volume":"49","author":[{"given":"Yucheng","family":"Zhang","sequence":"first","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"},{"name":"Division of General Internal Medicine, Department of Medicine, University Health Network and Sinai Health, University of Toronto 2 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalton","family":"Budhram","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"},{"name":"Division of Endocrinology, Department of Medicine, University of Toronto 3 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Bapat","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"},{"name":"Division of Endocrinology, Department of Medicine, University of Toronto 3 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Dhaliwal","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethan","family":"Parikh","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda","family":"Gad","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Orszag","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajeeha","family":"Cheema","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmohsen","family":"Bakhsh","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"},{"name":"Division of Endocrinology, Department of Medicine, University of Toronto 3 , Toronto, Ontario, Canada"},{"name":"Kidney & Pancreas Health Centre, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital & Research Centre, Alfaisal University 4 , Riyadh, Kingdom of Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha J.","family":"Verhoeff","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanna","family":"Weisman","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"},{"name":"Division of Endocrinology, Department of Medicine, University of Toronto 3 , Toronto, Ontario, Canada"},{"name":"Institute for Clinical Evaluative Sciences 5 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fralick","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"},{"name":"Division of General Internal Medicine, Department of Medicine, University Health Network and Sinai Health, University of Toronto 2 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah M.","family":"Ivers","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, Women\u2019s College Hospital 6 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Z.I.","family":"Cherney","sequence":"additional","affiliation":[{"name":"Division of Nephrology, University Health Network, University of Toronto 7 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tomlinson","sequence":"additional","affiliation":[{"name":"Institute of Health Policy, Management and Evaluation, University of Toronto 8 , Toronto, Ontario, Canada"},{"name":"Toronto General Hospital Research Institute 9 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Mumford","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif Erik","family":"Lovblom","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"},{"name":"Biostatistics Department, University Health Network 10 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5885-0046","authenticated-orcid":false,"given":"Bruce A.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital 1 , Toronto, Ontario, Canada"},{"name":"Division of Endocrinology, Department of Medicine, University of Toronto 3 , Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"2026102014522599200_B1","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrendo.2016.15","article-title":"Diabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia","volume":"12","author":"Umpierrez","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"2026102014522599200_B2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/dc24-2385","article-title":"Longitudinal determination of diabetes complications and other clinical variables as risk factors for diabetic ketoacidosis in type 1 diabetes","volume":"48","author":"Bapat","year":"2025","journal-title":"Diabetes Care"},{"key":"2026102014522599200_B3","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2337\/dc23-0840","article-title":"Point-of-care capillary blood ketone measurements and the prediction of future ketoacidosis risk in type 1 diabetes","volume":"46","author":"Song","year":"2023","journal-title":"Diabetes Care"},{"key":"2026102014522599200_B4","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.2337\/dc25-0125","article-title":"Capillary ketone level and future ketoacidosis risk in patients with type 1 diabetes using sodium-glucose cotransporter inhibitors","volume":"48","author":"Bapat","year":"2025","journal-title":"Diabetes Care"},{"key":"2026102014522599200_B5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.2337\/dc18-1749","article-title":"Empagliflozin as adjunctive to insulin therapy in type 1 diabetes: the EASE Trials","volume":"41","author":"Rosenstock","year":"2018","journal-title":"Diabetes Care"},{"key":"2026102014522599200_B6","unstructured":"Boehringer Ingelheim.\n          \n          Clinical trial protocol: a phase III, randomised, double blind, placebo-controlled, parallel group, efficacy, safety and tolerability trial of once daily, oral doses of empagliflozin as adjunctive to insulin therapy over 26 weeks in patients with type 1 diabetes mellitus (EASE-3), 2016. Accessed 24 July 2026. Available from https:\/\/cdn.clinicaltrials.gov\/large-docs\/91\/NCT02580591\/Prot_000.pdf"},{"key":"2026102014522599200_B7","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1080\/01621459.2023.2197686","article-title":"Cross-validation: what does it estimate and how well does it do it?","volume":"119","author":"Bates","year":"2024","journal-title":"J Am Stat Assoc"},{"key":"2026102014522599200_B8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1541-0420.2005.00324.x","article-title":"Nonparametric estimation of ROC curves in the absence of a gold standard","volume":"61","author":"Zhou","year":"2005","journal-title":"Biometrics"},{"key":"2026102014522599200_B9","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1177\/096228029800700402","article-title":"Analysis of clustered data in receiver operating characteristic studies","volume":"7","author":"Beam","year":"1998","journal-title":"Stat Methods Med Res"},{"key":"2026102014522599200_B10","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198509844.001.0001","volume-title":"The Statistical Evaluation of Medical Tests for Classification and Prediction.","author":"Pepe","year":"2003"},{"key":"2026102014522599200_B11","doi-asserted-by":"crossref","unstructured":"Chen\n              T\n            , GuestrinC.\n          XGBoost: a scalable tree boosting system. Proc ACM SIGKDD Int Conf Knowl Discov Data Min2016:785\u2013794","DOI":"10.1145\/2939672.2939785"},{"key":"2026102014522599200_B12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"2026102014522599200_B13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"2026102014522599200_B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v028.i05","article-title":"Building predictive models in R using the caret package","volume":"28","author":"Kuhn","year":"2008","journal-title":"J Stat Soft"},{"key":"2026102014522599200_B15","unstructured":"The R Foundation\n          . R: the R Project for Statistical Computing. Accessed 22 March 2026. Available from https:\/\/www.r-project.org\/"},{"key":"2026102014522599200_B16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/dom.15921","article-title":"Continuous ketone monitoring: exciting implications for clinical practice","volume":"26(","author":"Kong","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2026102014522599200_B17","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S2213-8587(25)00331-6","article-title":"Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology","volume":"14","author":"Dhatariya","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026102014522599200_B18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcjd.2025.11.002","article-title":"Barriers to diabetic ketoacidosis prevention in adults with type 1 diabetes: implications for education and implementation of new monitoring technologies","volume":"50","author":"Verhoeff","year":"2026","journal-title":"Can J Diabetes"},{"key":"2026102014522599200_B19","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jcjd.2025.10.003","article-title":"A patient and healthcare professional co-designed diabetic ketoacidosis educational infographic for type 1 diabetes","volume":"49","author":"Waniss","year":"2025","journal-title":"Can J Diabetes"},{"key":"2026102014522599200_B20","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/11\/2008\/893772\/dc261110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/49\/11\/2008\/893772\/dc261110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:52:34Z","timestamp":1792522354000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/49\/11\/2008\/172426\/The-Minimum-Frequency-of-Well-Day-Capillary-Blood"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,8,28]]},"published-print":{"date-parts":[[2026,11,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc26-1110","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}